2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith...

25
2011 February 11 Johannesburg

Transcript of 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith...

Page 1: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

2011 February 11

Johannesburg

Page 2: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Exco 2011 introduction Savi Chetty-Tulsee (Chair) Independent Judith Ramuthaga (Vice) Pharma Tebogo Sebata (Treasurer) Pharma Robert Voogt (Secretary CT) Laboratory Diederik van Niekerk (Bloem) Independent Dr Francois Burger CRO & Investigator Natalie Dresse Logistics Nicky Sulzer Study Coordinator Dr Luthando Adams SMO & Investigator Catherine Lund CRO Barbara Sematimba Full time administrator

Page 3: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Updates of 2010 activity

Sub-group activities CRA unit standard development Regulatory working group for CTF review Facilitation of the GCP sub-committee of

stakeholders (SCT chair of committee) ITG meetings with registrar and

development of good relations with MRA

Page 4: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Updates of 2010 activity Regulatory approval timeline tracking Dispensing w/group

Collaboration with PIASA for common objectives

Marketing of SA Survey on regulatory barriers in SA

Journal of Clinical studies Jan11articles

Page 5: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Updates

CRA Unit Standards: Still at the CHIETA SGB – no news

Regulatory w/group review of CTF: Completed review of CTF1, 2 and 3. Pending progress report. Requested meeting with MRA to discuss proposed changes

Page 6: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Update GCP subcommittee of industry stakeholders

Approval by HPCSA to review and accredit GCP providers

2011 – all providers to submit applications to HPCSA accreditor ( CPD2A form + GCP provider application forms)

CPD accreditation to serve as educational point allocation as well as confirmation that the GCP provider meets the industry set criteria

9Feb11: Training of HPCSA accreditors on the review of the application process conducted

Page 7: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Update ITG has requested a meeting with the

SAHPRA project w/group to get a status update

MCC review and approval timeline tracking will recommence Feb11.

Collaboration with PIASA will continue Development of a marketing SA package Survey of regulatory barriers report and

liaison with stakeholders Dispensing License – legal review (in

progress)

Page 8: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Updates

Publications Encourage positive publications on SA Education initiatives to increase lay

persons’ clinical trial knowledge

Page 9: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Recognition of excellence Site of the Year Clinical Research Associate of the Year Study Site Coordinator of the YearThe person nominating the individual needs to check against the

criteria in providing a brief summary of their experiences with working with the individual and provide examples of how this person went “over and above the call of duty”. This will help the judges in the decision making process. Any suggestions??

Nominations open on SACRA website Send emails to SACRA Coordinator

Visit website for criteria!!

Page 10: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Expectations from our membership

Increased members across stakeholders

Increased membership involvement in activities and projects

Increased interaction through use of technology

Pride, support and loyalty from within membership

Page 11: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

2011 stakeholder focus

Page 12: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Sites & Study Coordinators (1)

Increasing site capacity by raising the awareness of clinical research amongst clinical staff.

There are many experienced clinicians in South Africa (doctors, nurses, allied health industry members) who potentially have a lot to add to our industry.

Information sessions to be hosted by relevant SACRA members in each area where interested parties can gather to hear what is involved in becoming a research site and receiving useful information and contacts.

Page 13: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Sites & Study Coordinators (2)

Increasing business skills’ knowledge amongst site staff. Clinical research is first and foremost a business & equipping relevant site staff with simple business skills is important to the efficient management of a site.

If the decision this year is to host a conference perhaps SACRA could once again invite Christine Pierre to host a ‘Site business skills’ workshop.

If there is to be no conference this year, perhaps SACRA & it’s partners could co-ordinate a site workshop where topics could include business skills, QC, SOP design and other topics suggested by interested attendees.

Page 14: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

  Service Providers (Natalie Dresse) Export Permit Information: May11 meeting

Application document completion Application process FAQ’s

IATA Training requirements for investigator sites: Last meeting IATA regulation training Roles & responsibilities in transportation

Page 15: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

SMO/Investigators (Dr Luthando Adams, Dr Francois Burger) 

Review of Investigator fees/ budgets based on submitted costs.

Review of Investigator sites payment terms. Capacity Building of sites Foster more early patient research activity in

SA Improve cross networking amongst Investigator Collaboration with PIASA/SACRA to develop a

marketing package/brochure

Page 16: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

CRO’s - Catherine Lund, Dr Francois Burger  Marketing and branding of SA Investigator database to be utilised by

CROs for clinical trial study related information

Bench marking survey on CRA salaries on the lines of expertise and skill set

Education initiative (articles in magazines to improve clinical research understanding)

Page 17: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Pharma- Tebogo Sebata    Judith Ramuthaga  

Continue ITG membership Restart MCC tracking Identify structure for corporate

membership fees Education initiative (articles in

magazines to improve clinical research understanding)

Page 18: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Independents - Savi Chetty-Tulsee, Diederik van

Niekerk To impress the importance for

continued education perhaps through small group meetings.

Maintaining communication network is a challenge.

The non involvement gaps identified may include budget constraints.

Propose a client & independents survey on what education the independents require.

Page 19: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

How often should the SACRA Conference be held How often should the SACRA Conference be

held? Bi-Annually (Every 2 Years)

32 62.7% Annually (No change)

11 21.6% Every 18 Months

8 15.7% Number of Voters: 51

Page 20: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

Website management, Yearly memberships carry yearly user name and password When renewing, it means you need to “re-register yearly !! Company invoices generated on the home-page-Public

menu-Multiple invoice request Individual invoices generated at the “Become a member” Or when you log on the your membership has expired, you

need to “renew here”. Choose payment option and please be careful to give

correct details Coupon code is then sent to you & needs to be used within

3 weeks to activate your access and log in into the members

Page 21: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

How to activate your account

Coupon Code: ZJG3YJ Valid for No. of Subscriptions: 1 Valid for Plans: Full Time Instructions:

1. Click the 'Become a Member' button on the right-hand side of the site. 2. Enter all your personal information and click 'Register'. 3. Select your Subscription Plan.

(You must choose one of the Existing Plans) 4. You can use either Offline Payment or Credit Card (as you will not be making an actual

payment). 5. Enter the Coupon Code for Full Time Membership (Existing Members) - this will apply a 100%

plan discount. 6. Complete the registration process.

Activate your Membership by clicking the activation link provided in the Activation E-mail which you will receive shortly after completing the process

Page 22: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

What’s new (1) The FDA amended the regulations governing the

informed consent process for clinical research studies of products regulated by the FDA, at 21 C.F.R. § 50.25(c).

This final rule was published on January 4, 2011 and it is effective March 7, 2011. The final rule requires that all informed consent documents for “applicable” drug (including biological product) and device clinical trials include a statement to inform individual subjects in the trials that a description of the clinical trial will be made available on the National Institutes of Health/National Library of Medicine (NIH/NLM) website at clinicaltrials.gov. The statement must also indicate clinicaltrials.gov will not include individually identifiable information. Compliance date: The compliance date of this final rule is March 7, 2012, for clinical trials that are initiated on or after the compliance date.

Page 23: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

What’s new (2)

FDA Draft Guidance for Industry: Electronic Source Documentation

in Clinical Investigations, December 2010

www.fda.org

Page 24: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

What’s new (3)

International Compilation of Human Research Protections

2011 Edition Compiled By:

Office for Human Research Protections, U.S. Department of Health and Human Services

http://www.hhs.gov/ohrp/international/

Page 25: 2011 February 11 Johannesburg. Exco 2011 introduction Savi Chetty-Tulsee (Chair)Independent Judith Ramuthaga (Vice)Pharma Tebogo Sebata (Treasurer)Pharma.

What’s new (3) cont. is a listing of over 1,000 laws,

regulations, and guidelines on human subjects protections in over 100 countries and from several international organizations. Many of the listings embed hyperlinks to the source document. These laws, regulations, and guidelines are classified into six categories:

General Drugs and Devices Privacy/Data Protection Human Biological Materials Genetic Issues Embryos, Stem Cells, and Cloning